Skip to main content
×
Home

Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia

  • Shanna L. Burke (a1), Peter Maramaldi (a2) (a3) (a4), Tamara Cadet (a2) (a3) and Walter Kukull (a5)
Abstract
ABSTRACT Background:

Alzheimer's disease (AD) is a neurodegenerative brain disease that causes cognitive impairment and dementia. Within the US, AD is the most common form of dementia in the elderly, affecting 1 in 10 people over the age of 65. Sleep disturbance has been called a “public health epidemic” and, like depression, is a prodromal symptom of AD but may also contribute to the risk of developing AD. It was hypothesized that sleep disturbance, depression, and the apolipoprotein E (APOE) genotype increase the likelihood of AD.

Methods:

Utilizing data from the National Alzheimer's Coordinating Center, information from evaluations of 11,453 cognitively asymptomatic participants was analyzed. Survival analysis was used to explore the independent relationships between depression, sleep disturbance, and APOE genotypes with eventual AD diagnosis. Cox proportional hazard models were utilized to explore the main effects and synergistic effects of psychosocial factors as moderated by APOE genotypes.

Results:

This study reinforced the association between APOE and AD. The hazard of developing AD was eight times higher for those with recent depression and the Ɛ4 homozygote (HR = 8.15 [3.70–17.95]). Among Ɛ4 carriers with clinician-verified depression, the hazard was ten times that of the reference group (HR = 10.11 [4.43–23.09]). The hazard for Ɛ4 carriers reporting sleep disturbance was almost 7 times greater than the reference group (HR = 6.79 [2.38–19.37]).

Conclusion:

Findings suggest that sleep disturbance, depression, and APOE Ɛ4 genotype are associated with AD during follow-up evaluations among a group of initially cognitively asymptomatic participants. This study contributes to the literature base exploring an increased hazard or risk of AD due to potential modifiable risk factors as well as genetic biomarkers, such as APOE.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia
      Available formats
      ×
Copyright
Corresponding author
Correspondence should be addressed to: Shanna L. Burke, PhD, MSW, LICSW, Florida International University, Robert Stempel College of Public Health and Social Work, School of Social Work, Modesto A. Maidique Campus, 11200 S.W. 8th Street, AHC5 564, Miami, Florida 33199, USA. Phone: +305-348-7462. Email: sburke@fiu.edu.
References
Hide All
Aboud O., Mrak R. E., Boop F. and Griffin S. T. (2012). Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience. BMC Medicine, 10, 3544. doi:10.1186/1741-7015-10-35.
Alzheimer's Association (2015). Alzheimer's disease facts and figures. Alzheimer's & Dementia, 11, 332384. doi: http://dx.doi.org/10.1016/j.jalz.2015.02.003.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Publishing.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Publishing.
Anderson K. N. and Bradley A. J. (2013). Sleep disturbance in mental health problems and neurodegenerative disease. Nature & Science of Sleep, 561575. doi: 10.2147/NSS.S34842.
Arnone D. et al. (2013). State dependent changes in hippocampal grey matter. Molecular Psychiatry, 18, 12651272.
Ballard C. Massey H., Lamb H. and Morris C. (1997). Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry, 63, 273273. doi: 10.1136/jnnp.63.2.273b
Barnes D. and Yaffe K. (2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurology, 10, 819828. doi: 10.1016/S1474-4422(11)70145-4.
Bateman R. et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine, 367, 795804.
Belsky D. W., Moffitt T. E. and Caspi A. (2013). Genetics in population health science: strategies and opportunities. American Journal of Public Health, 103 (S1), S73S83.
Brainerd C. J., Reyna V. F., Petersen R. C., Smith G. E. and Taub E. S. (2011). Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. Neuropsychology, 25, 679689. doi: 10.1037/a0024483.
Brainerd C. J. et al. (2013). The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study. Neuropsychology, 27, 8694. doi: 10.1037/a0030855.
Buckley J. D. (1984). Additive and multiplicative models for relative survival rates. Biometrics, 40, 5162.
Cantillon M., Barker W., Harwood D., Mullan M. and Duara R. (1996). Phenotype of depression in Alzheimer's disease (AD) with APOE genotype. Biological Psychiatry, 39, 661.
Caraci F., Copani A., Nicoletti F. and Drago F. (2010). Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. European Journal of Pharmacology, 626, 6471.
Centers for Disease Control and Prevention (2013, March). Underlying mortality data provided by national center for health statistics. Retrieved October 27, 2013, from http://www.cdc.gov/nchs/data/databriefs/db116.pdf.
Chui H. C., Zheng L., Reed B. R., Vinters H. V. and Mack W. J. (2012). Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimer's Research and Therapy, 4, 113. doi:10.1186/alzrt98.
Corder E. H. et al. (1993). Gene dose of apolipoprotein E type allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921923.
Corder E. H. et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 181184.
Cox D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society, Series B, 34, 187220.
Cummings J. L. (1997). The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology, 48, S10S16.
de-Almada B. V. P. et al. (2012). Protective effect of the APOE-e3 allele in Alzheimer's disease. Brazilian Journal of Medical and Biological Research, 45, 812.
de Oliveira F. F., Ferreira Bertolucci P. H., Chen E. S. and Smith M. C. (2014). Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia. Neurology India, 62, 625630. doi:10.4103/0028-3886.149384.
Donix M., Small G. W. and Bookheimer S. Y. (2012). Family history and APOE-4 genetic risk in Alzheimer's disease. Neuropsychological Review, 22, 298309. doi: 10.1007/s11065-012-9193-2.
Efron B. (1977). The efficiency of Cox's likelihood function for censored data. Journal of the American Statistical Association, 72, 557565.
Farrer L. A. et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA, 278, 13491356.
Fortune D. A., Lang R., Cook S. and Byrd G. S. (2013). African Americans and Alzheimer's disease: role of health educators in addressing this silent epidemic. American Journal of Health Studies, 28, 92100.
Ghebranious N. et al. (2011). A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clinical Medicine & Research, 9, 1725. doi: 10.3I2l/cmr.20I0.894.
Gil-Bea F. J. et al. (2010). HPA axis dysregulation associated to apolipoprotein e4 genotype in Alzheimer's disease. Journal of Alzheimer's Disease, 22, 829838. doi: 10.3233/JAD-2010-100663.
Harwood D. G., Barker W. W., Ownby R. L., Mullan M. and Duara R. (2004). No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly. International Journal of Geriatric Psychiatry, 19, 11311139. doi:10.1002/gps.1193.
Hollingworth P., Harold D., Jones L., Owen M. J. and Williams J. (2011). Alzheimer's disease genetics: current knowledge and future challenges. International Journal of Geriatric Psychiatry, 26, 793802. doi: 10.1002/gps.2628.
Hollingworth P. et al. (2006). Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. Journal of the American Geriatrics Society, 54, 13481354.
Kaufer D. I. et al. (2000). Validation of the NPI-Q: a brief clinical form of the neuropsychiatric inventory. The Journal of Neuropsychiatry and Clinical Neurosciences, 12, 233239.
Kleinbaum D. G. and Klein M. (2012). Survival Analysis: A Self-Learning Text, 3rd edn. New York: Springer.
Kumar A. and Chanana P. (2014). Sleep reduction: a link to other neurobiological diseases. Sleep and Biological Rhythms, 12, 150161. doi:10.1111/sbr.12066.
Lee H. J. and Dugan E. (2015). How large is the gap between self-report and assessed mental health and does it impact older adult mental health service utilization?. Journal of Gerontological Social Work, 58, 319. doi:10.1080/01634372.2014.919978.
Lim A., Yu L., Kowgier M., Schneider J., Buchman A. and Bennett D. (2013). Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurology, 70, 15441551. doi:10.1001/jamaneurol.–.4215.
López-León S. S. et al. (2008). Meta-analyses of genetic studies on major depressive disorder. Molecular Psychiatry, 13, 772785. doi:10.1038/sj.mp.4002088.
Luciano M. et al. (2015). Current versus lifetime depression, APOE variation, and their interaction on cognitive performance in younger and older adults. Psychosomatic Medicine, 77, 480492. doi: 10.1097/PSY.0000000000000190.
Lyketsos C. G. and Olin J. (2002). Depression in Alzheimer's disease: overview and treatment. Biological Psychiatry, 52, 243252.
Marques S. F., Oliveira C. R., Outeiro T. F. and Pereira C. F. (2010). Alzheimer's disease: the quest to understand complexity. Journal of Alzheimer's Disease, 21, 373383. doi:10.3233/JAD2010100303.
McKhann G., Drachman D., Folstein M., Katzman R., Price D. and Stadlan E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34, 939944.
McKhann G. et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 263269. doi:10.1016/j.jalz.2011.03.005.
Mendelsohn A. R. and Larrick J. W. (2013). Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases. Rejuvenation Research, 18, 518523. doi: 10.1089/rej.2013.1530.
Meng X. and D'Arcy C. (2013). Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors. International Journal of Geriatric Psychiatry, 28, 10051014. doi: 10.1002/gps.3918.
Morris J. C. et al. (2006). The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer's disease centers. Alzheimer Disease and Associated Disorders, 20, 210216.
Multhammer M., Michels A., Zintl M., Mendoza M. C. and Klünemann H. H. (2014). A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease. Acta Neurologica Belgica, 114, 2531.
National Alzheimer's Coordinating Center (2010). The UDS study population. Retrieved from: https://www.alz.washington.edu/WEB/study_pop.html.
Nikodemova M., Finn L., Mignot E., Salzieder N. and Peppard P. E. (2013). Association of sleep disordered breathing and cognitive deficit in APOE Ɛ4 carriers. Sleep, 36, 873880. doi:10.5665/sleep.2714.
Osorio R. S. et al. (2014). The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiology of Aging, 35, 13181324. doi:10.1016/j.neurobiolaging.2013.12.030.
Peavy G. M. et al. (2007). The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biological Psychiatry, 62, 472478.
Pistacchi M., Gioulis M., Contin F., Sanson F. and Marsala S. Z. (2014). Sleep disturbance and cognitive disorder: epidemiological analysis in a cohort of 263 patients. Journal of the Neurological Sciences. doi: 10.1007/s10072-014-1870-x.
Portney L. G. and Watkins M. P. (2009). Foundations of Clinical Research: Applications to Practice, 3rd edn. Upper Saddle River, NJ: Pearson Education, Inc.
Qiu C., Xu W., Winblad B. and Fratiglioni L. (2010). Vascular risk profiles for dementia and Alzheimer's disease in very old people: a population-based longitudinal study. Journal of Alzheimer's Disease, 20, 293300. doi: 10.3233/JAD-2010-1361.
Reitz C., Tang M. X., Schupf N., Manly J. J., Mayeux R. and Luchsinger J. A. (2010). A summary risk score for the prediction of Alzheimer disease in elderly persons. Archives of Neurolology, 67, 835841. doi: 10.1001/archneurol.2010.136.
Saunders A. et al. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 14671472.
Schipper H. M. (2011). Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiology of Aging, 32, 778790. doi:10.1016/j.neurobiolaging.2009.04.021.
Segal A. Z. (2013). Poor sleep quality may predict preclinical Alzheimer's disease. Neurology Alert, 31, 8688.
Sheline Y. I., Gado M. H. and Kraemer H. C. (2003) Untreated depression and hippocampal volume loss. American Journal of Psychiatry, 160, 15161519.
Sperling R. A. et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 280292. doi:10.1016/j.jalz.2011.03.003.
Spira A. P. et al. (2013). Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurology, 70, 15371543.
StataCorp (2015). Stata Statistical Software: Release 14. College Station, TX: StataCorp LP.
Talbot C., Lendon C., Craddock N., Shears S., Morris J. C. and Goate A. (1994). Protection against Alzheimer's disease with APOE epsilon 2. Lancet, 343, 14321433.
Thies W. and Bleiler L. (2013). 2013 Alzheimer's disease facts and figures. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 9, 208245. doi:10.1016/j.jalz.2013.02.003.
Virta J. et al. (2013). Midlife sleep characteristics associated with late life cognitive function. Sleep, 36, 15331541. doi:10.5665/sleep.3052.
Weintraub S. et al. (2009). The Alzheimer's disease centers’ uniform data set (UDS): the neuropsychological test battery. Alzheimer Disease and Associated Disorders, 23, 91. doi: 10.1097/WAD.0b013e31819c7dd.
Weldemichael D. A. and Grossberg G. T. (2010). Circadian rhythm disturbances in patients with Alzheimer's disease: a review. International Journal of Alzheimer's Disease, 2010, 19. doi:10.4061/2010/716453.
Xie L. et al. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342, 373377. doi:10.1126/science.1241224.
Yesavage J. A. et al. (2004). Sleep/Wake disruption in Alzheimer's disease: APOE status and longitudinal course. Journal of Geriatric Psychiatry & Neurology, 17, 2024. doi:10.1177/0891988703261994.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 116
Total number of PDF views: 481 *
Loading metrics...

Abstract views

Total abstract views: 1161 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st November 2017. This data will be updated every 24 hours.